<DOC>
	<DOCNO>NCT02511704</DOCNO>
	<brief_summary>The purpose study 1 ) determine pharmacokinetics nicotine multiple dose administration electronic cigarette 2 ) compare acute effect multiple dose nicotine administrate electronic cigarette compare obteined cigarette .</brief_summary>
	<brief_title>Pharmacokinetics Acute Effects Multiple Dose Nicotine : Electronic Cigarette Cigarette</brief_title>
	<detailed_description>Electronic cigarette ( e-cigarettes ) battery-operated device deliver nicotine via inhaled vapour `` vaping '' . At present , e-cigarettes become increasingly popular among smoker worldwide . However , knowledge e-cigarette nicotine pharmacology remain limited . The aim study 1 ) determine pharmacokinetics nicotine multiple dose administration electronic cigarette 2 ) compare acute effect multiple dose nicotine administrate electronic cigarette compare obteined cigarette .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Understanding accept study procedure sign informed consent . Male adults volunteer ( 1845 year old ) . Clinical history physical examination demonstrate organic psychiatric disorder . The ECG general blood urine laboratory test perform study within normal range . Minor occasional change normal range accept , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject interfere product assessment . These change nonrelevance justify write specifically . Present use nicotine without serious adverse reaction . Smokers â‰¥ 3 cigarettes/day . Having suffer cardiovascular and/or respiratory disease three month prior study start . History drug dependence ( except nicotine dependence ) . Daily consumption &gt; 4 standard unit ethanol . Regular use drug month prior study session . The treatment single limited dos symptomatic medicinal product week prior study session reason exclusion calculate cleared completely day experimental session . Having suffer organic disease major surgery three month prior study start . Blood donation 12 week participation clinical trial drug previous 12 week . History clinical evidence gastrointestinal , liver , renal disorder may lead suspect disorder drug absorption , distribution , metabolism excretion , suggest gastrointestinal irritation due drug . Subjects unable understand nature , consequence study procedure request follow . Use drug substance inhibitor cytochrome P4501A6 ( CYP1A6 ) ( p.e . raloxifene , coumarins , etc )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Nicotine</keyword>
	<keyword>Electronic cigarette</keyword>
	<keyword>Cigarette</keyword>
</DOC>